CS
MDCO

Credit Suisse’s Medicines Co MDCO Stock Holding History

Credit Suisse’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-25,000
Closed -$2.12M – 4398
2019
Q4 		$2.12M Buy
+25,000
New +$1.67M ﹤0.01% 2551

Other funds holding MDCO

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Credit Suisse's MDCO Position: Q1 2020 in Review

Credit Suisse sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 2,884,978 shares — an estimated $245M sold.

Credit Suisse first reported a position in MDCO in Q2 2013 and held it in 27 quarters. The position peaked at $245M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

  • Credit Suisse reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
  • Credit Suisse sold 2,884,978 Medicines Co shares in Q1 2020, an estimated $245M.
  • Credit Suisse first reported a position in Medicines Co in Q2 2013 and held it in 27 quarters.
  • Credit Suisse's Medicines Co position peaked at $245M in Q4 2019.
  • 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Credit Suisse's 13F filing for Q1 2020, filed 13 May 2020.